See more What is this medication? DONEPEZIL (doe NEP e zil) treats memory loss and confusion (dementia) in people who have Alzheimer disease
Dementia is a Donepezil is used to treat dementia (memory loss and mental changes) associated with mild, moderate, or severe Alzheimer's disease
Donepezil (Aricept) is a once-daily, oral medication used for dementia related to Alzheimer's disease (AD)
It’s approved by the Food and Drug
The starting dosage of Aricept for dementia is 5 mg once per day
) were designed to evaluate the efficacy and safety of donepezil in people with mild to moderately severe dementia due to Alzheimer's disease and one study ( )
Nausea, vomiting, and diarrhea are the three most common side effects of Aricept
loss of appetite
Aricept is used to treat mild, moderate and severe Aricept; Descriptions
Do not use in larger or smaller amounts or for longer than recommended
Donepezil puede ayudar a mejorar la función mental, pero no funciona igual en todas las personas
In clinical trials, these digestive side effects became more common at higher doses Donepezil is used to treat confusion related to Alzheimer's disease
For additional information about Aricept, including details about its benefits and uses, see this article
Some people may experience mild to serious side effects during Aricept treatment
It is more popular than comparable drugs
Common side effects of Aricept ODT may include: nausea, vomiting, diarrhea; loss of appetite; muscle cramps; sleep problems ( insomnia ); or
Current recommendations and cautions for donepezil use
Rivastigmine (Exelon®): approved for mild-to-moderate Alzheimer’s as well as mild-to-moderate dementia associated with Parkinson’s disease
Three cholinesterase inhibitors are commonly prescribed: Donepezil (Aricept) is approved to treat all stages of the disease
Read all information given to you
For children: It hasn’t been established that donepezil is safe or effective for use in children under the age of 18 years
7) • Cholinesterase inhibitors should be prescribed with care to patients with a Azmacort